drugset / Trial / NCT02645591
Randomized AmnioFix Study During Radical Prostatectomy
RandomizedParallel-groupSingle-blindTreatment
Summary
The goal of this clinical research study is to learn about the safety and the effectiveness of using AmnioFix® (dehydrated human amnion/chorion membrane, also called dHACM) to help improve the return of erectile function and bladder control in patients after robotic assisted laparoscopic radical prostatectomy (RARP). dHACM is a section of tissue made from part of the placenta donated by a mother during a C-section. It looks like a small piece of tissue paper and is wrapped around the nerve bundles in the surgical area. The tissue may help the body's normal healing process.
Timeline
- Start
- 2016-11
- Primary completion
- 2019-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dehydrated human amnion/chorion membrane | Unknown | — | Other |